|
Over the past 30 years, HIV has infected over 60 million people, with almost half succumbing to AIDS-related illnesses.While antiretroviral therapy, used to significantly reduce within-host HIV replication, was available within 10 years of the discovery of HIV/AIDS, it is only within the last 10 years that it has become truly effective and universally accessible. However, there are problems with this therapy, not least that it must be administered indefinitely , but is expensive and highly toxic. Furthermore, as therapy reaches more resource-limited regions, continual access can not be guaranteed, resulting in therapy interruptions. This, coupled with a significant cost reduction by systematically interrupting therapy, means a set of models which can account for both treatment events need to be developed, as numerous models exist for therapy introduction, but those for therapy removal are limited. Thus a set of delay differential models are designed, which account for previously ove...
|